News | December 16, 2009

CT Calcium Detection Aids in Ruling Out Obstructive Coronary Disease


December 16, 2009 - Non-enhanced CT for calcium detection is a reliable way to exclude obstructive coronary artery disease in patients with chest pain, according to a study published in the December issue of the American Journal of Cardiology.

While is a well established option for , particularly when stress tests are inconclusive or not feasible, Concerns surrounding radiation and contrast exposure prompted researchers, led by Dr. Koen Nieman and colleagues from Erasmus Medical Center, Rotterdam, The Netherlands, to investigate alternative diagnostic techniques for evaluating patients with chest pain other than CT angiography (CTA).

To compare the effectiveness of coronary calcium scores (CCS), CTA, and exercise electrocardiography (XECG) for detecting obstructive coronary disease, researchers evaluated 471 patients with new stable chest pain.

In eight patients (1.7 percent), neither CCS nor CTA was possible. In an additional eight, CTA could not be performed for various reasons. All of the calcium scans were successful, while three CTAs failed. XECG was not possible in 48 patients (10.2 percent) and was inconclusive in 140 of 423 patients (33 percent). Ninety-eight patients underwent catheter angiography, with 57 found to have at least 50 percent diameter obstruction.

Overall, 175 patients (37 percent) had a negative CCS. Three of these (2 percent) had significant CAD on CT angiograms, only one of which was confirmed by quantitative angiography.

In patients with a high CCS (Agatston of more than 400; n = 65), CTA could exclude obstructive CAD in no more than four (6 percent). CT was more often diagnostic in patients with a low-intermediate CCS (10 to 400; n = 175), and could rule out obstructive CAD in 56 percent of patients.

Few cases of obstructive disease were detected in patients with a low CCS (less than 10; n = 48), although these patients had evidence of atherosclerotic disease.

Overall, 42 percent of patients had positive CT angiograms. These patients had significant stenosis on quantitative angiogram more often when exercise electrocardiogram was also positive.

For patients with diagnostic results for all tests, the sensitivity and specificity to detect significant coronary stenosis were 100 percent and 16 percent for CCS of more than zero, 82 percent and 64 percent for CCS of more than 100, 97 percent and 36 percent for CTA, and 70 percent and 76 percent for XECG, respectively.

The type of tests preferred for the workup of suspected CAD - functional, or anatomical - is still up for debate. "Although XECG is considered more cost effective, it has poor diagnostic performance," the researchers noted.

The researchers concluded, similar to a negative stress test result, a negative CCS also has an excellent prognosis. This suggests that a negative CCS could suffice to rule out obstructive CAD without the need for further testing.

For more information:www.ajconline.org


Related Content

News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
Subscribe Now